The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants
Abstract
Background Indomethacin is used as standard therapy to close a patent ductus arteriosus (PDA) but is associated with reduced blood flow to several organs. Ibuprofen, another cyclo‐oxygenase inhibitor, may be as effective as indomethacin with fewer side effects. Objectives To determine the efficacy and safety of ibuprofen for closing a PDA in preterm and/or low birth weight infants. Seperate comparisons are presented for 1. ibuprofen (iv) compared with placebo; 2. ibuprofen (oral) compared with placebo; 3. ibuprofen (oral or iv) compared with other cyclo‐oxygenase inhibitors (given iv or orally); 4. ibuprofen (oral) versus indomethacin (given iv or orally); 5. ibuprofen (oral) versus iv ibuprofen; 6. high dose versus standard dose of iv ibuprofen; 7. early versus expectant administration of iv ibuprofen. Search methods We searched The Cochrane Library, MEDLINE, EMBASE, Clincialtrials.gov, Controlled‐trials.com, www.abstracts2view.com/pas, and personal files in July 2012. Selection criteria Randomised or quasi‐randomised controlled trials of ibuprofen for the treatment of a PDA in newborn infants. Data collection and analysis Data collection and analysis conformed to the methods of the Cochrane Neonatal Review Group. Main results Twenty‐seven studies are included in this review. One study (n = 136) compared iv ibuprofen versus placebo. Ibuprofen reduced the composite outcome of infant deaths, infants who dropped out or required rescue treatment; risk ratio (RR) 0.58 (95% confidence interval (CI) 0.38 to 0.89); risk difference (RD) ‐0.22 (95% CI ‐0.38 to ‐06); number needed to benefit (NNTB) 5 (95% CI 3 to 17). One study (n = 64) compared oral ibuprofen with placebo. There was a significant reduction in the failure rate to close a PDA; RR 0.26 (95% CI 0.11 to 0.62); RD ‐0.44 (95% CI ‐0.65 to ‐0.23); NNTB 2 (95% CI 2 to 4). Failure rates for PDA closure with ibuprofen (oral or iv) compared with indomethacin (oral or iv) was reported in 20 studies (n = 1019 infants). There was no significant difference between the groups; typical RR 0.98 (95% CI 0.80 to 1.20) I2 = 0%; typical RD ‐0.01 (95% CI ‐0.06 to 0.05); I2 = 0%. The risk of developing necrotising enterocolitis (NEC) was reduced for ibuprofen (15 studies (n = 865); typical RR 0.68 (95% CI 0.47 to 0.99); typical RD ‐0.04 (95% CI ‐0.08 to ‐0.00; (P = 0.04); NNTB 25 (95% CI 13, infinity); I2 = 0%). The duration of ventilatory support was reduced with ibuprofen (oral or iv) compared with iv or oral indomethacin (six studies, n = 471) mean difference (MD) ‐2.35 days (95% CI ‐3.71 to ‐0.99); I2 = 19%. Failure rates for PDA closure with oral ibuprofen compared with indomethacin (oral or iv) were reported in seven studies (n = 189 infants). There was no significant difference between the groups; typical RR 0.82 (95% CI 0.52 to 1.29); typical RD ‐0.06 (95% CI ‐0.18 to 0.06). The risk of NEC was reduced with oral ibuprofen compared with indomethacin (oral or iv) six studies (n = 166); typical RR 0.44 (95% CI 0.23 to 0.82); RD ‐0.15 (95% CI ‐0.25 to ‐0.04); NNTB 7 (95% CI 4 to 25). There was no heterogeneity for this outcome. There was a decreased risk of failure to close a PDA with oral ibuprofen compared with iv ibuprofen, three studies (n = 236) typical RR 0.37 (95% CI 0.23 to 0.61); typical RD ‐0.24 (95% CI ‐0.35 to ‐0.13); NNTB 4 (95% CI 3 to 8). There was less evidence of transient renal insufficiency in infants who received ibuprofen compared with indomethacin. High dose versus standard dose of iv ibuprofen and early versus expectant administration of iv ibuprofen have only been studied in two trials. Authors' conclusions Ibuprofen is as effective as indomethacin in closing a PDA and reduces the risk of NEC and transient renal insufficiency. Given the reduction in NEC ibuprofen currently appears to be the drug of choice. Oro‐gastric administration of ibuprofen appears at least as effective as iv administration. Too few patients have been enrolled in studies assessing the effectiveness of a high dose of ibuprofen versus the standard dose and early versus expectant administration of ibuprofen to make recommendations. Studies are needed to evaluate the effect of ibuprofen compared with indomethacin treatment on longer‐term outcomes in infants with PDA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Estimating the mean and variance from the median, range, and the size of a sample
Hozo, S. P., Djulbegovic, B., & Hozo, I. (2005) · BMC Medical Research Methodology · doi:10.1186/1471-2288-5-13 · Cited by 9,062
Long-Term Effects of Indomethacin Prophylaxis in Extremely-Low-Birth-Weight Infants
Schmidt, B., Davis, P., Moddemann, D., Ohlsson, A., Roberts, R. S., Saigal, S., Solimano, A., Vincer, M., & Wright, L. L. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106283442602 · Cited by 725
Self-citationVariations in Practice and Outcomes in the Canadian NICU Network: 1996–1997
Lee, S. K., McMillan, D. D., Ohlsson, A., Pendray, M., Synnes, A., Whyte, R., Chien, L.-Y., Sale, J., & the Canadian NICU Network (2000) · Pediatrics · doi:10.1542/peds.106.5.1070 · Cited by 490
Self-citationProphylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants
Fowlie, P. W., Davis, P. G., & McGuire, W. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000174.pub2 · Cited by 480
WHITTLE, P. M. (1998) · Archives of Disease in Childhood - Fetal and Neonatal Edition · doi:10.1136/fn.79.2.f160 · Cited by 472
A Comparison of Ibuprofen and Indomethacin for Closure of Patent Ductus Arteriosus
Van Overmeire, B., Smets, K., Lecoutere, D., Van de Broek, H., Weyler, J., De Groote, K., & Langhendries, J.-P. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009073431001 · Cited by 447
Effects of indomethacin on cerebral haemodynamics in very preterm infants
Edwards, A. D., Wyatt, J. S., Richardson, C., Potter, A., Reynolds, E. O. R., Cope, M., & Delpy, D. T. (1990) · The Lancet · doi:10.1016/0140-6736(90)93030-s · Cited by 296
Pezzati, M., Vangi, V., Biagiotti, R., Bertini, G., Cianciulli, D., & Rubaltelli, F. F. (1999) · The Journal of Pediatrics · doi:10.1016/s0022-3476(99)70093-4 · Cited by 246
Patel, J., Roberts, I., Azzopardi, D., Hamilton, P., & Edwards, A. D. (2000) · Pediatric Research · doi:10.1203/00006450-200001000-00009 · Cited by 225
Cited by
Sweet, D. G., Carnielli, V., Greisen, G., Hallman, M., Ozek, E., Plavka, R., Saugstad, O. D., Simeoni, U., Speer, C. P., Vento, M., et al. (2013) · Neonatology · doi:10.1159/000349928 · Cited by 550
Patent Ductus Arteriosus of the Preterm Infant
Hamrick, S. E. G., & Hansmann, G. (2010) · Pediatrics · doi:10.1542/peds.2009-3506 · Cited by 543
Prevention and Management of Procedural Pain in the Neonate: An Update
COMMITTEE ON FETUS AND NEWBORN and SECTION ON ANESTHESIOLOGY AND PAIN MEDICINE, Keels, E., Sethna, N., Watterberg, K. L., Cummings, J. J., Benitz, W. E., Eichenwald, E. C., Poindexter, B. B., Stewart, D. L., Aucott, S. W., et al. (2016) · Pediatrics · doi:10.1542/peds.2015-4271 · Cited by 515
Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants
Fowlie, P. W., Davis, P. G., & McGuire, W. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000174.pub2 · Cited by 480
Benitz, W. E. (2010) · Journal of Perinatology · doi:10.1038/jp.2010.3 · Cited by 345
Metadata
- Authors
- Ohlsson, A., Walia, R., & Shah, S. S.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- John Wiley & Sons, Ltd
- Published
- 2013-04-30
- ISSN
- 1361-6137 (ISSN-L)
- OpenAlex
- W4360755604
- Cited by
- 263
- References
- 19
- Type
- reference entry
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. https://app.cochat.ai/papers/10.1002/14651858.cd003481.pub5
- The paper
- Ohlsson, A., Walia, R., & Shah, S. S. (2013). Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd003481.pub5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.